DGAP-News

STRATEC reports on first nine months of 2016 (news with additional features)

DGAP-News: STRATEC Biomedical AG / Key word(s): Quarterly / Interim
Statement/Quarter Results
STRATEC reports on first nine months of 2016 (news with additional features)

27.10.2016 / 07:23
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

STRATEC reports on first nine months of 2016


- Sales of EUR 126.3 million in 9M/2016 (+17.8%;9M/2015: EUR 107.2 million)
- EBIT margin of 14.6%(1) in 9M/2016 (9M/2015: 17.9%)
- Further growth in workforce due to full development pipeline
- New development agreements signed


Birkenfeld, October 27, 2016


STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard,
TecDAX) today announced its financial results for the period from January
1, 2016 through to September 30, 2016 with the publication of its Quarterly
Statement 9M|2016.


Major key figures

in EUR thousand                01.01.-            01.01.-         Change
                            09.30.2016         09.30.2015
Sales                          126,334            107,200         +17.8%
EBITDA(1)                       22,671             23,368          -3.0%
EBITDA margin (%)(1)              17.9               21.8       -390 bps
EBIT(1)                         18,391             19,235          -4.4%
EBIT margin (%)(1)                14.6               17.9       -330 bps
Consolidated net income (2)     15,251             15,916          -4.2%
Earnings per share (EUR) (2)      1.29               1.35          -4.4%

bps=basis points


(1) 2016 figure adjusted for one-off items resulting from transaction
activities and related reorganization expenses

(2) 2016 figure additionally adjusted for financing expenses and tax
expenses in connection with the acquisitions of the Diatron Group and
STRATEC Consumables, for one-off items resulting from the tax audit for the
2009 to 2013 assessment periods, and for tax effects relating to
reorganization expenses



Business performance
The Group increased its sales for the first nine months of 2016 by 17.8% to
EUR 126.3 million (previous year: EUR 107.2 million). This substantial
growth was mostly attributable to the sales contributed by the Diatron
Group and STRATEC Consumables, which have been consolidated for the first
time since April 1, 2016 and July 1, 2016 respectively. The negative impact
of regulatory procedures taking longer than planned and persistent turnover
weakness at one customer since the beginning of the year was offset by
positive call-up figures for various systems.